Bipolar disorder, obesity, and pharmacotherapy-associated weight gain.
about
Add-on topiramate reduces weight in overweight patients with affective disorders: a clinical case seriesNeurocognitive functioning in overweight and obese patients with bipolar disorder: data from the Systematic Treatment Optimization Program for Early Mania (STOP-EM)Inflammation: opportunities for treatment stratification among individuals diagnosed with mood disorders.Use pattern and off-label use of atypical antipsychotics in bipolar disorder, 1998-2002Preliminary findings regarding overweight and obesity in pediatric bipolar disorder.History of manic and hypomanic episodes and risk of incident cardiovascular disease: 11.5 year follow-up from the Baltimore Epidemiologic Catchment Area StudyMetabolic dysfunction in women with bipolar disorder: the potential influence of family history of type 2 diabetes mellitus.A review of bipolar disorder in adults.Psychiatric disorders of patients seeking obesity treatmentThe Drosophila ETV5 Homologue Ets96B: Molecular Link between Obesity and Bipolar Disorder.Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care.Zonisamide for bipolar disorder, mania or mixed states: a randomized, double blind, placebo-controlled adjunctive trial.Aripiprazole monotherapy in patients with rapid-cycling bipolar I disorder: an analysis from a long-term, double-blind, placebo-controlled study.Investigating the safety and efficacy of naltrexone for anti-psychotic induced weight gain in severe mental illness: study protocol of a double-blind, randomized, placebo-controlled trialEffects of pectin lyase-modified red ginseng extracts in high-fat diet-fed obese miceCarbamazepine in bipolar disorder with pain: reviewing treatment guidelinesThe burden of obesity among adults with bipolar disorder in the United StatesCentral nervous system delivery of the antipsychotic olanzapine induces hepatic insulin resistanceA 52-week, double-blind evaluation of the metabolic effects of aripiprazole and lithium in bipolar I disorder.Effect of Early Intervention with Omega-3 on Insulin Resistance in Patients Initiated on Olanzapine with either Sodium Valproate or Lithium: A randomized, Double-blind, Placebo-Controlled Trial.Metabolic syndrome in bipolar disordersCan body mass index help predict outcome in patients with bipolar disorder?Obesity and the three-year longitudinal course of bipolar disorder.Gender differences in associations between body mass index and DSM-IV mood and anxiety disorders: results from the National Epidemiologic Survey on Alcohol and Related ConditionsPhentermine, sibutramine and affective disorders.A wellness intervention program for patients with mental illness: self-reported outcomes.Prevalence and correlates of eating disorder co-morbidity in patients with bipolar disorder.Zonisamide for Bipolar Depression: A Randomized, Double Blind, Placebo-Controlled, Adjunctive Trial.Metabolic syndrome and central obesity in depression: A cross-sectional study.Valproic acid is a novel activator of AMP-activated protein kinase and decreases liver mass, hepatic fat accumulation, and serum glucose in obese mice.The relationship of chronic medical illnesses, poor health-related lifestyle choices, and health care utilization to recovery status in borderline patients over a decade of prospective follow-up.Molecular Mechanisms of Bipolar Disorder: Progress Made and Future Challenges.Olanzapine-induced weight gain in patients with bipolar I disorder: a meta-analysis.Gender differences in mood stabilizer medications prescribed to Veterans with serious mental illness.An Oldie but Goodie: Lithium in the Treatment of Bipolar Disorder through Neuroprotective and Neurotrophic Mechanisms.
P2860
Q24793223-59321515-0A30-4E16-807A-D6E3EA0EE195Q30897232-B68D8225-FB3F-4BDB-B39D-10D72AFB7661Q33721019-CF16BA49-9926-44D4-A9A4-3293AE8D2958Q33932148-22FF45C6-ACB1-4EC2-9AE3-25C391473C0DQ34024177-DA4FDED9-6692-4975-A3ED-79585338ACD7Q34071117-A2B0B4FA-6E30-4564-9636-4C4F541073CAQ34137064-888843DA-1484-42B1-B4D2-CF3D2944583BQ34237178-46B91C23-2B68-43C6-A0E0-46A47F0A4BDAQ34529638-79E7B38A-8C98-4CD2-9187-438534FB983FQ34530223-40CA1ADA-D33A-4F7A-B9B0-CB47E12BF930Q34623350-E4EB9F72-12B6-4DE2-ABBC-61D021F20752Q34637512-4E469589-62AB-4476-AAB3-0D57591EE51BQ34655996-F502940C-17BB-4B35-B7B8-B6947E052CE9Q34785866-A43DC358-45FC-4FF8-A4BE-F7CC28D53014Q35014337-EEDD42AC-B478-456C-B7CF-CD0C44D2A8EDQ35061890-7BF7ECF2-ACE0-4C60-89B8-5ABDCF21DAEEQ35167517-5F04D12C-0C71-435F-89A2-7CD4ADD1BCDEQ35757166-1919C54F-DB72-4969-88F6-E212460B2788Q35833294-F8329C82-8B1D-4B32-BE83-5BE805D5E396Q36197756-F2B4B626-CAB9-4A84-862D-283D11816785Q36400968-AA3C16D0-7C08-4969-8465-7E2B49989292Q36532159-298142A1-B4F9-452A-8CD0-36D9F0E17BE4Q36751327-97507DBD-431F-482E-9571-A18AC029467FQ36824980-963F0391-FFE6-4D9E-8D0D-3B68CE7854F7Q36832356-AF12B23B-A139-4AF2-8FA2-CDF3D10B58AAQ36859550-26F1EB39-EF16-471B-A417-A5F28A76EAE6Q37098549-1DE79E26-E19F-497C-BBC5-8277982BAE9DQ37299907-3296F2CB-F33E-46BF-9A6A-36A2F16CC403Q37400542-C0889818-9DB1-40CF-9D7C-384E165761E1Q37405427-45C3A7C9-9292-462C-AD78-5EF41F328579Q37449605-AC46670B-2C7F-4981-BAB3-CD8ADCC412ADQ37639334-FA1ED95F-D918-4DED-8FE6-F0BD1F48648DQ37997775-4B825714-9786-488B-B842-7A0E071DDDC6Q40549171-2AE4DE3A-F739-4767-ABBA-719EE3102623Q47294091-ACE564F1-2A2B-42ED-B25E-35B7469C2A91
P2860
Bipolar disorder, obesity, and pharmacotherapy-associated weight gain.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Bipolar disorder, obesity, and pharmacotherapy-associated weight gain.
@ast
Bipolar disorder, obesity, and pharmacotherapy-associated weight gain.
@en
type
label
Bipolar disorder, obesity, and pharmacotherapy-associated weight gain.
@ast
Bipolar disorder, obesity, and pharmacotherapy-associated weight gain.
@en
prefLabel
Bipolar disorder, obesity, and pharmacotherapy-associated weight gain.
@ast
Bipolar disorder, obesity, and pharmacotherapy-associated weight gain.
@en
P921
P356
P1476
Bipolar disorder, obesity, and pharmacotherapy-associated weight gain
@en
P2093
Paul E Keck
Susan L McElroy
P304
P356
10.4088/JCP.V64N1205
P577
2003-12-01T00:00:00Z